In honor of World Cancer Day
Your Weekly Shortcut to Deeptech Investing—Exclusive Trends & Startup Reports for VCs & Angels in Just 5 Minutes
By Sarah Amouyal, Deeptech Expert
Cancer remains among the most lethal diseases globally; however, there is optimism on the horizon. These leading 20 startups leverage artificial intelligence in cancer research, diagnosis, and treatment to advance life-saving endeavors. From enhancing early detection to refining treatment approaches, these startups employ AI to significantly impact the battle against cancer.
Cancer IQ, a US-based startup established in 2013, offers a precision prevention platform that empowers healthcare providers to engage patients, assess risk, and ensure adherence to the latest evidence-based strategies for cancer prevention. By providing a comprehensive content library of evidence-based guidelines and risk models, Cancer IQ assists providers in interpreting data and guiding patients towards appropriate genetic testing, screening, or treatment interventions. Funding: $20M. Noteworthy Projects:
CancerIQ’s Screening Toolkit and Navigator
CancerIQ Self-Assessment and Specialist
Panakeia, founded in 2018 in the UK, simplifies cancer diagnosis by eliminating the need for multiple tests, making it faster, cheaper, and more efficient. Project: PANProfiler Breast - A breast cancer diagnostic tool that analyzes tissue slides to report ER, PR, and HER2 status.
MultiplAI Health, established in the UK in 2019, utilizes advancements in genomics and artificial intelligence to develop universal remote screening. Project: MultiplAI Superbiomarker - Offers a whole blood screening test using RNA Sequencing and AI to detect various complex diseases, including cardiovascular disorders and cancer.
X-Zell, a Singaporean biotechnology company founded in 2014, specializes in early cancer detection. Funding: $5.6M. Project: X-Zell Single-cell Detection Technology - Integrates next-generation single-cell detection technology with AI to identify clinically significant cancers at their earliest stages, non-invasively, accurately, and affordably.
MNM Bioscience Inc., based in the USA and founded in 2018, combines cutting-edge genomics with AI to combat cancer, aiming to decipher the complexities of tumor biology. Funding: $2.6M. Notable Projects:
ARETEAI platform - Integrates proprietary databases with advanced AI algorithms to decode tumor biology.
MNM177 - Identifies a novel drug target associated with DNA damage response and replication stress pathways.
Omdena, along with Mango Science, a Boston-based startup, embarked on a project to enhance cancer patient care. The Omdena team explored various survival analysis models to find the most effective algorithms. These algorithms predict a patient's survival probability and the ideal timing for specific, often more affordable, treatments. Mango Science is a leading data science company that focuses on connecting millions of underserved patients to precision medicine through its Querent™ platform. This platform employs advanced AI analytics to convert complex clinical data into actionable insights, driving improvements in global health.
Savor Health, established in the USA in 2018, offers personalised nutritional strategies to manage cancer symptoms and side effects.
Other notable startups to have a look at include:
Concr, a UK-based company using machine learning to predict cancer progression accurately.
Biotome, an Australian startup developing a simple blood test for stomach cancer screening.
Quantaras, a US company providing advanced medical image quantification solutions.
Vivan Therapeutics, a UK company pioneering personalized cancer therapeutics.
iLoF, a US-based startup enabling personalized medicine through AI-based nanostructure identification.
AEYE Health, a US digital health startup offering AI algorithms for immediate, autonomous interpretation of fundus images.
Theator, a US-based surgical intelligence platform improving surgeon performance using AI and computer vision.
Medivis, a US company integrating various expertise to enhance surgical outcomes through augmented reality and AI.
Tambua Health, a US startup transforming respiratory disease diagnosis and treatment through lung sound analysis.
C the Signs, a UK startup providing an AI-powered platform for early cancer detection and intervention.
These are just a few examples of the pioneering companies globally that are leveraging AI to revolutionise cancer research, diagnosis, and treatment, ultimately impacting and improving lives.